Bridging Gaps in Brain Health Research
More than 210,000 people in North Carolina have Alzheimer's disease, and many others have other types of dementia. The North Carolina Registry for Brain Health aims to help relieve the burden by educating North Carolinians, giving them an opportunity to participate in research, and helping researchers recruit study volunteers.
Therapy Shows Promise in Delaying Hospitalizations for Heart Failure
A large international study led by Duke researchers found that the diabetes drug empagliflozin slowed the time to first hospitalization for heart failure and reduced the total number of subsequent heart failure hospitalizations in patients after they had suffered acute myocardial infarction.
Allan D. Kirk, MD, PhD, Awarded 2024 ASA Flance-Karl Award
Allan D. Kirk, MD, PhD, FACS, has been awarded the 2024 Flance-Karl Award by the American Surgical Association (ASA). The Flance-Karl Award recognizes surgeons in the U.S. who have made seminal contributions in basic laboratory research which has application to clinical surgery.
Personalized Model Unveils Hidden Patterns in Alzheimer’s Progression
A new mathematical model offers hope for better prediction and treatment of Alzheimer’s disease.
Mary E. Klotman's Message for Friday, March 29, 2024
Dr. Klotman shares news about new funding, Match Day, Distinguished Professorships and more.
EDI Spotlight: Debra Ragland, PhD
For Debra Ragland, PhD, who works closely with PhD students in the School of Medicine, addressing issues related to equity, diversity, and inclusion in the biosciences is simple. She says it’s a matter of creating a supportive environment where the students feel heard.
The Power and Promise of RNA
Scientists at Duke University School of Medicine have long probed the mysteries of RNA, with an eye to harnessing its power for new and better therapies for cancer, diabetes, heart disease and more.
Duke Awarded Up to $33 Million to Develop Osteoarthritis Therapies that Rebuild Bone and Joints
Duke Health is part of a multi-institution research team receiving funding from the federal Advanced Research Projects Agency for Health (ARPA-H) to develop an osteoarthritis treatment that regenerates joints.
Team Builder’s Gift Launches Heart Innovation Hub
Bob Keegan is empowering a pioneering Duke Health team with a transformational gift to kick-start the new Duke Heart Precision and Innovation Collaboratory.
Palliative Care Improves Quality of Life for Bone Marrow Transplant Patients
Palliative care -- relief from symptoms -- significantly improves a patient’s quality of life and eases fatigue, depression and post-traumatic stress symptoms while they are hospitalized for bone marrow transplant.